fcmedicineФундаментальная и клиническая медицинаFundamental and Clinical Medicine2500-07642542-0941КемГМУ10.23946/2500-0764-2025-10-2-15-31fcmedicine-1016Research ArticleЭПИДЕМИОЛОГИЯEPIDEMIOLOGYРоль клинических рекомендаций по профилактике и лечению сердечно-сосудистых заболеваний в снижении бремени болезней системы кровообращенияThe role of clinical guidelines in reducing the burden of cardiovascular diseases.https://orcid.org/0000-0003-4146-4787ПолибинР. В.PolibinR. V.

Полибин Роман Владимирович, кандидат медицинских наук, доцент, заместитель директора по научной работе Института общественного здоровья им. Ф. Ф. Эрисмана, доцент кафедры эпидемиологии и доказательной медицины

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048

Dr. Roman V. Polibin, MD, Cand. Sci. (Medicine), Chief Scientific Officer, Erismann Institute of Public Health; Associate Professor, Department of Epidemiology and Evidence-based Medicine

Trubetskaya Street, 8, Building 2, Moscow, 119048

polibin_r_v@staff.sechenov.ruhttps://orcid.org/0000-0003-2121-4975ПетуховаИ. В.PetukhovaI. V.

Петухова Ирина Вячеславовна, ординатор кафедры эпидемиологии и доказательной медицины

ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048

Dr. Irina V. Petukhova, MD, Clinical Resident, Department of Epidemiology and Evidence-Based Medicine

Trubetskaya Street, 8, Building 2, Moscow, 119048

Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)РоссияSechenov First Moscow State Medical University (Sechenov University)Russian Federation2025300620251021531Copyright © Полибин Р.В., Петухова И.В., 20252025Полибин Р.В., Петухова И.В.Polibin R.V., Petukhova I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://fcm.kemsmu.ru/jour/article/view/1016

Цель. Оценить влияние внедрения во врачебную практику клинических рекомендаций (КР) по кардиологии в Российской Федерации (РФ) и некоторых странах Европейского региона на динамику смертности от сердечно-сосудистых заболеваний (ССЗ). Материалы и методы. Выборка данных о смертности от ССЗ была проведена с использованием базы данных Global Burden of Disease. Распределение стран на 5 кластеров по уровню смертности осуществлялось с помощью кластерного анализа. Информация об используемых КР была получена на сайтах профессиональных сообществ и по данным российских и зарубежных публикаций. Проведен эпидемиологический анализ смертности от ССЗ в периоды до и после внедрения КР. Проведены оценка динамики смертности и сравнение темпов прироста до и после внедрения КР. Результаты. После внедрения КР выявлено снижение смертности в Испании, Эстонии, России, Латвии, Республике Беларусь, Украине и более выраженный темп снижения в Великобритании и Нидерландах. Снижение смертности в Бельгии, Франции, Словакии, Италии, Португалии, Германии, Чехии обусловлено успешно реализуемыми кампаниями по профилактике ССЗ, внедрению и использованию КР в медицинской практике. Рост смертности в Хорватии, Сербии, Боснии и Герцеговине, Литве, Румынии и Болгарии связан с ограниченными экономическими возможностями, препятствующими полноценной реализации превентивных и лечебных программ. Заключение. Внедрение КР по ССЗ в систему здравоохранения сыграло важную роль в снижении смертности. Для достижения максимального эффекта от внедрения КР во врачебную практику необходима комплексная стратегия, обеспечивающая доступность качественной медицинской помощи для всего населения, в том числе программ профилактики и реабилитации, достаточный объем финансирования, включая современное оснащение медицинских организаций, подготовку и повышение уровня квалификации медицинских кадров. Лишь при условии интеграции КР в систему здравоохранения с обеспечением реализации изложенных в них направлений профилактики, диагностики и лечения можно достичь значительного снижения заболеваемости и смертности от ССЗ

Aim. To assess the impact of implementing evidencebased cardiology guidelines into the clinical practice in the Russian Federation and selected European countries on trends in cardiovascular disease (CVD) mortality. Materials and Methods. Mortality data were obtained from the Global Burden of Disease database. Countries were grouped into five clusters based on CVD mortality rates. Information on implemented clinical guidelines was gathered from professional society websites and published national and international sources. We further conduced an epidemiological analysis of CVD mortality before and after the implementation of clinical guidelines, including before-after analysis of mortality trends. Results. After the implementation of clinical cardiology guidelines, a reduction in CVD mortality was observed in Spain, Estonia, Russia, Latvia, Belarus, Ukraine, and especially United Kingdom and the Netherlands. Decrease in mortality in Belgium, France, Slovakia, Italy, Portugal, Germany, and the Czech Republic was associated with successful CVD prevention campaigns and active use of clinical cardiology guidelines in clinical practice. Increased mortality in Croatia, Serbia, Bosnia and Herzegovina, Lithuania, Romania, and Bulgaria was linked to limited economic resources that hindered full implementation of preventive and treatment programs. Conclusion. The integration of CVD clinical guidelines into the national healthcare systems has played a significant role in reducing mortality. Achieving the full potential of CG implementation requires a comprehensive strategy that ensures access to quality care for the entire population, including preventive and rehabilitation programs, sufficient funding, modern infrastructure, and continuous professional development of healthcare personnel. Systemic integration of guideline-based prevention, diagnostics, and treatment can further reduce CVD morbidity and mortality

сердечно-сосудистые заболеваниясмертностьклинические рекомендацииcardiovascular diseasemortalityclinical guidelinesReferencesКосолапов В.П., Ярмонова М.В. Анализ высокой сердечно-сосудистой заболеваемости и смертности взрослого населения как медико-социальной проблемы и поиск путей ее решения. Уральский Медицинский Журнал. 2021;20(1):58–64. https://doi.org/10.52420/2071-5943-2021-20-1-58-64Kosolapov VP, Yarmonova MV. The analysis of high cardiovascular morbidity and mortality in the adult population as a medical and social problem and the search for ways to solve it. Ural Medical Journal. 2021;20(1):58–64. (In Russ.). https://doi.org/10.52420/2071-5943-2021-20-1-58-64Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M. et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J. Am. Col.l Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010Pyorala K., De Backer G., Graham I., Poole-Wilson P., Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension. Atherosclerosis. 1994;110(2):121–161. https://doi.org/10.1016/0021-9150(94)90200-3Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension. Atherosclerosis. 1994;110(2):121–161. https://doi.org/10.1016/0021-9150(94)90200-3Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur. Heart J. 1998;19(10):1434–1503. https://doi.org/10.1053/euhj.1998.1243Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19(10):1434– 1503. https://doi.org/10.1053/euhj.1998.1243De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J. et al. European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur. J. Cardiovasc. Prev. Rehabil. 2003;10(4):S1-S10. https://doi.org/10.1097/01.hjr.0000087913.96265.e2De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1-S10.https://doi.org/10.1097/01.hjr.0000087913.96265.e2Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R. et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2007;28(19):2375–2414. https://doi.org/10.1093/eurheartj/ehm316Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28(19):2375–2414. https://doi.org/10.1093/eurheartj/ehm316Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012;33(13):1635– 1701. https://doi.org/10.1093/eurheartj/ehs092Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–1701. https://doi.org/10.1093/eurheartj/ehs092Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano А.L., et al. Linee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica. Sesta Task Force congiunta della Società Europea di Cardiologia e di altre Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da rappresentanti di 10 società e da esperti invitati). Redatte con il contributo straordinario dell’Associazione Europea per la Prevenzione e Riabilitazione Cardiovascolare (EACPR). G. Ital. Cardiol. 2017;18(7):547–612. https://doi.org/10.1714/2729.27821Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano АL, et al. Linee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica. Sesta Task Force congiunta della Società Europea di Cardiologia e di altre Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da rappresentanti di 10 società e da esperti invitati). Redatte con il contributo straordinario dell’Associazione Europea per la Prevenzione e Riabilitazione Cardiovascolare (EACPR). G Ital Cardiol. 2017;18(7):547–612. https://doi.org/10.1714/2729.27821Visseren F.L.J., Mach F., Smulders Y.M., Carballo D., Koskinas K.C., Bäck M. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021;42(34):3227–3337. https://doi.org/10.1093/eurheartj/ehab484Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. https://doi.org/10.1093/eurheartj/ehab484European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 2003;21(6):1011–1053. https://doi.org/10.1097/00004872-200306000-00001European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011–1053. https://doi.org/10.1097/00004872-200306000-00001Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2007;28(12):1462–1536. https://doi.org/10.1093/eurheartj/ehm236Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462–1536. https://doi.org/10.1093/eurheartj/ehm236Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Böhm M. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013;34(28):2159–219. https://doi.org/10.1093/eurheartj/eht151Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. https://doi.org/10.1093/eurheartj/eht151Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018;39(33):3021–3104. https://doi.org/10.1093/eurheartj/ehy339Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. https://doi.org/10.1093/eurheartj/ehy339Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A. et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J. Hypertens. 2023;41(12):1874–2071. https://doi.org/10.1097/HJH.0000000000003480Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. https://doi.org/10.1097/HJH.0000000000003480Treating mild hypertension. Report of the British Hypertension Society working party. BMJ. 1989;298(6675):694–698. https://doi.org/10.1136/bmj.298.6675.694Treating mild hypertension. Report of the British Hypertension Society working party. BMJ. 1989;298(6675):694–698. https://doi.org/10.1136/bmj.298.6675.694Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J. et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993;306(6883):9837. https://doi.org/10.1136/bmj.306.6883.983Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993;306(6883):983–987. https://doi.org/10.1136/bmj.306.6883.983Ramsay L., Williams B., Johnston G., MacGregor G., Poston L., Potter J. et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J. Hum. Hypertens. 1999;13(9):569–592. https://doi.org/10.1038/sj.jhh.1000917Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999;13(9):569–592. https://doi.org/10.1038/sj.jhh.1000917Williams B., Poulter N.R., Brown M.J., Davis M., McInnes G.T., Potter J.F. et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J. Hum. Hypertens. 2004;18(3):139–185. https://doi.org/10.1038/sj.jhh.1001683Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18(3):139–185. https://doi.org/10.1038/sj.jhh.1001683OECD/European Observatory on Health Systems and Policies. Czech Republic: Country Health Profile 2017, State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2017. http://dx.doi.org/10.1787/9789264283336-enOECD/European Observatory on Health Systems and Policies. Czech Republic: Country Health Profile 2017, State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2017. http://dx.doi.org/10.1787/9789264283336-enHagemeister J., Schneider C.A., Barabas S., Schadt R., Wassmer G., Mager G. et al. Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness. J. Hypertens. 2001;19(11):2079–2086. https://doi.org/10.1097/00004872-200111000-00020Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G et al. Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness. J Hypertens. 2001;19(11):2079–2086. https://doi.org/10.1097/00004872-200111000-00020Predel H.G., Graas F., Rudinger G., Randerath O. Management of arterial hypertension: Transfer from clinical guidelines into daily practice – Results of a survey in German practitioners offices. J. Educ. Health Promot. 2020;9:34. https://doi.org/10.4103/jehp.jehp_426_19Predel HG, Graas F, Rudinger G, Randerath O. Management of arterial hypertension: Transfer from clinical guidelines into daily practice – Results of a survey in German practitioners offices. J Educ Health Promot. 2020;9:34. https://doi.org/10.4103/jehp.jehp_426_19Donfrancesco C., Noce C.L., Lonardo A.D., Vannucchi S., PalmieriL. Progetto CUORE: health examination survey e studi longitudinali a supporto della prevenzione cardiovascolare. Boll. Epidemiol. Naz. 2021;2(4):12-21. https://doi.org/10.53225/BEN_032Donfrancesco C, Noce CL, Lonardo AD, Vannucchi S, Palmieri L. Progetto CUORE: health examination survey e studi longitudinali a supporto della prevenzione cardiovascolare. Boll Epidemiol Naz. 2021;2(4):12-21. https://doi.org/10.53225/BEN_032OECD, European Observatory on Health Systems and Policies. Portugal: Country Health Profile 2023. State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2023. https://doi.org/10.1787/069af7b1-enOECD, European Observatory on Health Systems and Policies. Portugal: Country Health Profile 2023. State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2023. https://doi.org/10.1787/069af7b1-enPilav A., Brankovic S., Doder V. Ten Year Trends in Cardiovascular Risk Factors in the Federation of Bosnia and Herzegovina. Med. Arch. 2014;68(6):394–398. https://doi.org/10.5455/medarh.2014.68.394-398Pilav A, Brankovic S, Doder V. Ten Year Trends in Cardiovascular Risk Factors in the Federation of Bosnia and Herzegovina. Med Arch. 2014;68(6):394–398. https://doi.org/10.5455/medarh.2014.68.394-398Fazlibegović E., Terzić I., Hadziomerovic M. Current uses of ISACSTC registry in Mostar. Int. J. Cardiol. 2016;217:S44–S46. https://doi.org/10.1016/j.ijcard.2016.06.224Fazlibegović E, Terzić I, Hadziomerovic M. Current uses of ISACSTC registry in Mostar. Int J Cardiol. 2016;217:S44–S46. https://doi.org/10.1016/j.ijcard.2016.06.224Ramic-Catak A., Mesihovic-Dinarevic S., Prnjavorac B., Naser N., Masic I. Public Health Dimensions of Cardiovascular Diseases (CVD) Prevention and Control – Global Perspectives and Current Situation in the Federation of Bosnia and Herzegovina. Mater. Socio-Medica. 2023;35(2):88–93. https://doi.org/10.5455/msm.2023.35.88-93Ramic-Catak A, Mesihovic-Dinarevic S, Prnjavorac B, Naser N, Masic I. Public Health Dimensions of Cardiovascular Diseases (CVD) Prevention and Control – Global Perspectives and Current Situation in the Federation of Bosnia and Herzegovina. Mater Socio-Medica. 2023;35(2):88–93. https://doi.org/10.5455/msm.2023.35.88-93Pilav A., Nissinen A., Haukkala A., Nikšić D., Laatikainen T. Cardiovascular Risk Factors in the Federation of Bosnia and Herzegovina. Eur. J. Public Health. 2007;17(1):75–79. https://doi.org/10.1093/eurpub/ckl066Pilav A, Nissinen A, Haukkala A, Nikšić D, Laatikainen T. Cardiovascular Risk Factors in the Federation of Bosnia and Herzegovina. Eur J Public Health. 2007;17(1):75–79. https://doi.org/10.1093/eurpub/ckl066Vlajinac H., Sipetic S., Saulic A., Atanackovic Z., Marinković J., Bjegovic V. Burden of ischaemic heart disease and cerebrovascular diseases in Serbia without Kosovo and Metohia, 2000. Eur. J. Cardiovasc. Prev. Rehabil. 2006;13(5):753–759. https://doi.org/10.1097/01.hjr.0000238395.04600.b5Vlajinac H, Sipetic S, Saulic A, Atanackovic Z, Marinković J, Bjegovic V. Burden of ischaemic heart disease and cerebrovascular diseases in Serbia without Kosovo and Metohia, 2000. Eur J Cardiovasc Prev Rehabil. 2006;13(5):753–759. https://doi.org/10.1097/01.hjr.0000238395.04600.b5Laucevičius A., Kasiulevičius V., Jatužis D., Petrulioniene Z. Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme - rationale and design. Semin. Cardiovasc. Med. 2012;18(1):1- 6. https://doi.org/10.2478/v10287-012-0003-3Laucevičius A, Kasiulevičius V, Jatužis D, Petrulioniene Z. Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme - rationale and design. Semin Cardiovasc Med. 2012;18(1):1-6. https://doi.org/10.2478/v10287-012-0003-3Simionescu M., Bilan S., Gavurova B., Bordea E.N. Health Policies in Romania to Reduce the Mortality Caused by Cardiovascular Diseases. Int. J. Environ. Res. Public Health. 2019;16(17):3080. https://doi.org/10.3390/ijerph16173080Simionescu M, Bilan S, Gavurova B, Bordea EN. Health Policies in Romania to Reduce the Mortality Caused by Cardiovascular Diseases. Int J Environ Res Public Health. 2019;16(17):3080. https://doi.org/10.3390/ijerph16173080OECD, European Observatory on Health Systems and Policies. Lietuva: 2023 m. Sveikatos Būklės Šalyje Apžvalga, State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2023. https://doi.org/10.1787/5ed683c8-enOECD, European Observatory on Health Systems and Policies. Lietuva: 2023 m. Sveikatos Būklės Šalyje Apžvalga, State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2023. https://doi.org/10.1787/5ed683c8-en.

The authors declare that there are no conflicts of interest present.